文獻(xiàn)引用
欣博盛生物科技有限公司(NeoBioscience Technology Co, Ltd)是一家致力于生命科學(xué)和生物技術(shù)領(lǐng)域的高科技企業(yè),公司由在國內(nèi)科研試劑領(lǐng)域有著十幾年從業(yè)經(jīng)驗的專業(yè)技術(shù)團隊和企業(yè)管理團隊組建而成,公司自主研發(fā)的ELISA試劑盒品質(zhì)卓越,行業(yè)領(lǐng)先,在國內(nèi)眾多重點實驗室得到廣泛使用,深受廣大科研工作者的好評。
欣博盛品牌ELISA自推出以來廣受權(quán)威認(rèn)可,得到多篇SCI文獻(xiàn)引用,其中包括Nature,Nature Immunology,PANS,Cell Research等頂刊文獻(xiàn)引用;同時有數(shù)千篇國內(nèi)核心期刊、博士及碩士論文引用。
欣博盛生物共有3214篇SCI文獻(xiàn)引用。您可以通過篩選功能查看感興趣的文獻(xiàn)。
文獻(xiàn) | 指標(biāo) | 種屬 | 樣本類型 |
---|---|---|---|
Junfang Zhao, Z. Z., Jialiang Sun, et al. A Novel Model of P-Glycoprotein Inhibitor Screening Using Human Small Intestinal Organoids. Basic clin pharmacol toxicol 2017 March (2017). Link | IHC kit | 常規(guī)樣本 | |
Zhang H, X. H., Chen H, et al. The inhibition of GHR enhanced cytotoxic effects of etoposide on neuroblastoma. Cellular Signalling 9 July 2021 (2021). Link | IHC kit | 常規(guī)樣本 | |
Li J, L. Y., Zhou X, et al. Upregulation of IL-15 in the placenta alters trophoblasts behavior contributing to gestational diabetes mellitus. Cell & Bioscience 8 February 2021 (2021). Link | IHC Kit | 常規(guī)樣本 | |
Dai L, C. X., Zhang X, et al. SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin. Nature Communications July, 2016 (2016). Link | VEGF bFGF PIGF-1 | Human | 常規(guī)樣本 |
Cheng F, Z. Y., Wang Y, et al. Conversion of human adipose-derived stem cells into functional and expandable endothelial-like cells for cell-based therapies. Stem Cell Research & Therapy 17 December 2018 (2018). Link | VEGF bFGF EGF IL-8 | Human | 常規(guī)樣本 |
Zhang Q, Y. D. Y., Xue B Z, et al. CD90 determined two subpopulations of glioma-associated mesenchymal stem cells with different roles in tumour progression. Cell Death & Disease 27 October 2018 (2018). Link | VEGF bFGF SDF-1α RANTES/CCL5 MMP-9 IL-6 | Human | 常規(guī)樣本 |
Du W J, C. Y., Yang Z X, et al. Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta. Stem Cell Research & Therapy 10 November 2016 (2016). Link | VEGF HGF bFGF | Human | 常規(guī)樣本 |
Guo H M, S. L., Yang L, et al. Microvesicles shed from bortezomib-treated or lenalidomide-treated human myeloma cells inhibit angiogenesis in vitro. Oncology reports April 23, 2018 (2018). Link | VEGF IL-6 bFGF | Human | 常規(guī)樣本 |
Tang Y, X. Q., Luo H, et al. Excessive IL-10 and IL-18 trigger hemophagocytic lymphohistiocytosis–like hyperinflammation and enhanced myelopoiesis. Journal of Allergy and Clinical Immunology 9 November 2022 (2022). Link | VEGF IL-6 | Human | 常規(guī)樣本 |
Li G, L. D., Wu C, et al. Homocysteine-targeting compounds as a new treatment strategy for diabetic wounds via inhibition of the histone methyltransferase SET7/9. . Experimental & Molecular Medicine 20 July 2022 (2022). Link | VEGF IL-8 | Human | 常規(guī)樣本 |